The drug rapamycin is being studied for its antiaging and fertility-preserving benefits — and the results seem promising.

In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of "The Hive", a novel scientific research hub located at its R&D centre in Barcelona, Spain. The ...

A more precise risk calculation would benefit diabetes screening programs that have become more common in the United States ...

The theme at SBM this week is questions for Trump's nominees for key health positions within the federal government. David ...

Digitalisation and AI in Orthopedic Surgery and Rehabilitation 4.0', and the rapidly evolving subject area, we are pleased to ...

ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...

Oncology drug development, approval, and access represent a rapidly evolving field that faces numerous challenges. The ...

By collecting data from four different antenna orientations post-surgery, researchers are detecting significantly more detailed information on breast cancer than a traditional single-orientation scan ...

Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...

At Scripps Research, a research team led by Associate Professor Anne Hanneken, in the Department of Molecular Medicine, will ...

Massachusetts General Brigham hospitals-led research has reported a significant increase in hospital-onset respiratory viral ...